Moreover, the relationship between CHRNB2 and aforementioned β-catenin pathway regulators was further verified in pancreatic cancer cell lines after overexpressing CHRNB2 (Fig. 6L). Here, CHRNB2 is linked to familial pancreatic carcinoma.